IL15 and neoplasm: Enhanced anti-tumor efficacy of CAR T cells with constitutive IL-7 and IL-15 signaling has also been reported, as well as with the inducible release of an IL-15 super-agonist complex by T cells upon interaction with the cognate antigen [34, 35].